Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Healthcare stocks are in focus as second-quarter earnings season shifts into high gear, with investors evaluating whether ...

Overview: Vertex leads the list with a $120B market cap, $12.95B–$13.1B revenue guidance, and strong growth from ALYFTREK and CASGEVY, reinforcing its biotech d ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.

On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and ...

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

Zhengye Biotechnology Holding Limited ZYBT shares plunged on Wednesday as traders reassessed the stock after an extreme, ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Vir Biotechnology has partnered with Astellas Pharma to develop VIR-5500, its masked PSMA-targeting T-cell engager for ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...

Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?